Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors
摘要:
Optimisation of ADS100380, a sub-micromolar HDAC inhibitor identified using a virtual screening approach, led to a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids (6a-i), that possessed significant HDAC inhibitory activity. Subsequent functionalisation of the pendent phenyl group of compounds 6f and 6g provided analogues 6j-w with further enhanced enzyme and anti-proliferative activity. Compound 6j demonstrated efficacy in a mouse xenograft experiment. (c) 2006 Elsevier Ltd. All rights reserved.
[EN] SUBSTITUTED THIENYL-HYDROXAMIC ACIDS AS HISTONE DEACETYLASE INHIBITORS<br/>[FR] ACIDES SUBSTITUES THIENYLHYDROXAMIQUES UTILISES EN TANT QU'INHIBITEURS D'HISTONE DESACETYLASE
申请人:ARGENTA DISCOVERY LTD
公开号:WO2004013130A1
公开(公告)日:2004-02-12
A compound of formula (I): which can be used in the treatment of diseases associated with histone deacetylase enzymatic activity.
化合物的化学式(I):可用于治疗与组蛋白去乙酰化酶活性相关的疾病。
Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors
作者:Steve Price、Walter Bordogna、Richard J. Bull、David E. Clark、Peter H. Crackett、Hazel J. Dyke、Matthew Gill、Neil V. Harris、Julia Gorski、Julia Lloyd、Peter M. Lockey、Julia Mullett、Alan G. Roach、Fabien Roussel、Anne B. White
DOI:10.1016/j.bmcl.2006.10.048
日期:2007.1
Optimisation of ADS100380, a sub-micromolar HDAC inhibitor identified using a virtual screening approach, led to a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids (6a-i), that possessed significant HDAC inhibitory activity. Subsequent functionalisation of the pendent phenyl group of compounds 6f and 6g provided analogues 6j-w with further enhanced enzyme and anti-proliferative activity. Compound 6j demonstrated efficacy in a mouse xenograft experiment. (c) 2006 Elsevier Ltd. All rights reserved.